BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Arthritis
,
Hypothalamus
,
Laryngoscope
,
Aspirin
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
EPC2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Esophageal squamous EPC2 cells with FOXF1 overexpression
Esophageal EPC2-T keratinocytes with or without activated Notch and TGFb1 treatment
Esophageal keratinocyte EPC2-T cell line subpopulations CD24-low CD44-high and CD24-high CD44-low
Esophageal keratinocyte EPC2-hTERT cells grown at air-liquid interface and interleukin 13 treated
Gene expression of esophageal epithelial cells exposed to moderate and severe hypoxia
Explore Curated Studies Results
Literature
Most Relevant Literature
DMM Outstanding Paper Prize 2019 winner: Alessandro Bailetti.
Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells.
Autophagy mitigates ethanol-induced mitochondrial dysfunction and oxidative stress in esophageal ker…
Nrf2/Keap1-Pathway Activation and Reduced Susceptibility to Chemotherapy Treatment by Acidification …
Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ